These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

346 related articles for article (PubMed ID: 9179529)

  • 1. Fludarabine. An update of its pharmacology and use in the treatment of haematological malignancies.
    Adkins JC; Peters DH; Markham A
    Drugs; 1997 Jun; 53(6):1005-37. PubMed ID: 9179529
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Fludarabine. A review of its pharmacological properties and therapeutic potential in malignancy.
    Ross SR; McTavish D; Faulds D
    Drugs; 1993 May; 45(5):737-59. PubMed ID: 7686467
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Multicentre prospective randomised trial of fludarabine versus cyclophosphamide, doxorubicin, and prednisone (CAP) for treatment of advanced-stage chronic lymphocytic leukaemia. The French Cooperative Group on CLL.
    Johnson S; Smith AG; Löffler H; Osby E; Juliusson G; Emmerich B; Wyld PJ; Hiddemann W
    Lancet; 1996 May; 347(9013):1432-8. PubMed ID: 8676625
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Role of fludarabine as monotherapy in the treatment of chronic lymphocytic leukemia.
    Leporrier M
    Hematol J; 2004; 5 Suppl 1():S10-9. PubMed ID: 15079149
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A systematic overview of chemotherapy effects in B-cell chronic lymphocytic leukaemia.
    Kimby E; Brandt L; Nygren P; Glimelius B;
    Acta Oncol; 2001; 40(2-3):224-30. PubMed ID: 11441934
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fludarabine: a review of its use in non-Hodgkin's lymphoma.
    Anderson VR; Perry CM
    Drugs; 2007; 67(11):1633-55. PubMed ID: 17661532
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Clinical experience with fludarabine in leukaemia.
    Keating MJ; Estey E; O'Brien S; Kantarjian H; Robertson LE; Plunkett W
    Drugs; 1994; 47 Suppl 6():39-49. PubMed ID: 7525188
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Clinical experience with fludarabine in indolent non-Hodgkin's lymphoma.
    Zinzani PL
    Hematol J; 2004; 5 Suppl 1():S38-49. PubMed ID: 15079152
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Rituximab plus fludarabine and cyclophosphamide or other agents in chronic lymphocytic leukemia.
    Robak T; Lech-Maranda E; Robak P
    Expert Rev Anticancer Ther; 2010 Oct; 10(10):1529-43. PubMed ID: 20942624
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [A new purine analog in the treatment of hematologic malignancy. I. Fludarabine].
    Vásová I; Penka M; Hájek R; Mayer J; Krahulcová E
    Vnitr Lek; 1997 Jan; 43(1):45-50. PubMed ID: 9221567
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Use of fludarabine in the treatment of mantle cell lymphoma, Waldenström's macroglobulinemia and other uncommon B- and T-cell lymphoid malignancies.
    Johnson SA
    Hematol J; 2004; 5 Suppl 1():S50-61. PubMed ID: 15079153
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Experience with fludarabine treatment and review of the literature].
    Telek B; Rejtó L; Kiss A; Batár P; Reményi G; Rák K; Udvardy M
    Orv Hetil; 2002 Jun; 143(24):1459-65. PubMed ID: 12138643
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pentostatin (Nipent) and chlorambucil with granulocyte-macrophage colony-stimulating factor support for patients with previously untreated, treated, and fludarabine-refractory B-cell chronic lymphocytic leukemia.
    Waselenko JK; Grever MR; Beer M; Lucas MA; Byrd JC
    Semin Oncol; 2000 Apr; 27(2 Suppl 5):44-51. PubMed ID: 10877052
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Fludarabine in lymphoproliferative malignancies: a single-centre experience.
    Prabhash K; Vikram GS; Nair R; Sengar M; Gujral S; Bakshi A; Gupta S; Parikh PM
    Natl Med J India; 2008; 21(4):171-4. PubMed ID: 19267037
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Oral fludarabine.
    Plosker GL; Figgitt DP
    Drugs; 2003; 63(21):2317-23. PubMed ID: 14524733
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Advancing therapy for chronic lymphocytic leukemia--the role of rituximab.
    Hillmen P
    Semin Oncol; 2004 Feb; 31(1 Suppl 2):22-6. PubMed ID: 15042531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Randomized phase III study of fludarabine phosphate versus cyclophosphamide, vincristine, and prednisone in patients with recurrent low-grade non-Hodgkin's lymphoma previously treated with an alkylating agent or alkylator-containing regimen.
    Klasa RJ; Meyer RM; Shustik C; Sawka CA; Smith A; Guévin R; Maksymiuk A; Rubinger M; Samosh M; Laplante S; Grenier JF
    J Clin Oncol; 2002 Dec; 20(24):4649-54. PubMed ID: 12488409
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotherapy combination treatment regimens with fludarabine in chronic lymphocytic leukemia.
    Hallek M; Eichhorst BF
    Hematol J; 2004; 5 Suppl 1():S20-30. PubMed ID: 15079150
    [TBL] [Abstract][Full Text] [Related]  

  • 19. New initiatives with fludarabine monophosphate in hematologic malignancies.
    Keating MJ; O'Brien S; Robertson LE; Kantarjian H; Dimopoulos M; McLaughlin P; Cabanillas F; Gregoire V; Yang LY; Gandhi V
    Semin Oncol; 1993 Oct; 20(5 Suppl 7):13-20. PubMed ID: 7694371
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High dose chlorambucil in the treatment of lymphoid malignancies.
    Nicolle A; Proctor SJ; Summerfield GP
    Leuk Lymphoma; 2004 Feb; 45(2):271-5. PubMed ID: 15101711
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.